730 related articles for article (PubMed ID: 10717780)
1. The effects of Implanon on lipid metabolism in comparison with Norplant.
Suherman SK; Affandi B; Korver T
Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
[TBL] [Abstract][Full Text] [Related]
2. A study on the effects of Norplant implantable contraceptive on lipid, lipoprotein, and apolipoprotein metabolism in Singaporean women.
Singh K; Ratnam SS
Contraception; 1997 Aug; 56(2):77-83. PubMed ID: 9315415
[TBL] [Abstract][Full Text] [Related]
3. Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids--a randomized comparative study.
Biswas A; Viegas OA; Roy AC
Contraception; 2003 Sep; 68(3):189-93. PubMed ID: 14561539
[TBL] [Abstract][Full Text] [Related]
4. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
5. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
Zheng SR; Zheng HM; Qian SZ; Sang GW; Kaper RF
Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
[TBL] [Abstract][Full Text] [Related]
6. Study of the effects of the implantable contraceptive Norplant on lipid and lipoprotein metabolism. UN Development Programme/UN Population Fund/WHO/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Contraception; 1999 Jan; 59(1):31-45. PubMed ID: 10342084
[TBL] [Abstract][Full Text] [Related]
7. Effects of Norplant contraceptive subdermal implants on serum lipids and lipoproteins.
Otubu JA; Towobola OA; Aisien AO; Ogunkeye OO
Contraception; 1993 Feb; 47(2):149-59. PubMed ID: 8449015
[TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
Anwar M; Soejono SK; Maruo T; Abdullah N
Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
[TBL] [Abstract][Full Text] [Related]
9. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
Mäkäräinen L; van Beek A; Tuomivaara L; Asplund B; Coelingh Bennink H
Fertil Steril; 1998 Apr; 69(4):714-21. PubMed ID: 9548163
[TBL] [Abstract][Full Text] [Related]
10. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
[TBL] [Abstract][Full Text] [Related]
11. Effect of Norplant implants on liver, lipid and carbohydrate metabolism.
Singh K; Viegas OA; Loke DF; Ratnam SS
Contraception; 1992 Feb; 45(2):141-53. PubMed ID: 1559336
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four month comparison of apolipoproteins A-1, A-II and B in contraceptive implant users (Norplant and Implanon) in Birmingham, United Kingdom.
Mascarenhas L; van Beek A; Bennink HC; Newton J
Contraception; 1998 Oct; 58(4):215-9. PubMed ID: 9866002
[TBL] [Abstract][Full Text] [Related]
13. Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD.
Croxatto HB; Diaz S; Robertson DN; Pavez M
Contraception; 1983 Mar; 27(3):281-8. PubMed ID: 6406139
[TBL] [Abstract][Full Text] [Related]
14. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
[TBL] [Abstract][Full Text] [Related]
15. Serum lipid profile in women using levonorgestrel contraceptive implant, Norplant-2.
Dash DS; Das S; Nanda U; Tripathy BB; Samal KC
Contraception; 1988 Apr; 37(4):371-82. PubMed ID: 3133159
[TBL] [Abstract][Full Text] [Related]
16. Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study.
Ng YW; Liang S; Singh K
Contraception; 2009 Jan; 79(1):24-8. PubMed ID: 19041437
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
Akerlund M; Almström E; Högstedt S; Nabrink M
Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
[TBL] [Abstract][Full Text] [Related]
18. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
[TBL] [Abstract][Full Text] [Related]
19. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
[TBL] [Abstract][Full Text] [Related]
20. Serum lipids in Norplant implants users: a cross-sectional study.
Affandi B; Suherman SK; Djajalelana ; Prihartono DJ; Lubis F; Samil RS
Contraception; 1987 Oct; 36(4):429-34. PubMed ID: 3127112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
